
InMed Pharmaceuticals Inc.
INMHealthcare|Drug Manufacturers - Specialty & Generic|CA
$15.56
+2.35 (+17.79%)
Cash / Share
$2074.83
Ownership Breakdown
84.4%
Float
0.5M
Shares Outstanding
0.5M
Float Shares
Major Holders (25)
Combined: 249.4%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Vivo Opportunity, LLC | Other | 21.70% | 718,444 | Jun 10, 2026 | 13D/G |
| Vivo Opportunity Fund Holdings, L.P. | Partnership | 21.70% | 718,444 | Jun 10, 2026 | 13D/G |
| ADAR1 Capital Management, LLC | IA, OO | 17.20% | 943,668 | Oct 7, 2026 | 13D/G |
| Daniel Schneeberger | HC, IN | 17.20% | 943,668 | Oct 7, 2026 | 13D/G |
| YA Global Investments II (U.S.), LP | Other | 9.99% | 80,372 | Dec 18, 2024 | 13D/G |
| YA II PN, Ltd. | Other | 9.99% | 80,372 | Dec 18, 2024 | 13D/G |
| Yorkville Advisors Global, LP | Other | 9.99% | 80,372 | Dec 18, 2024 | 13D/G |
| Yorkville Advisors Global II, LLC | Other | 9.99% | 80,372 | Dec 18, 2024 | 13D/G |
| Ya II GP, LP | Other | 9.99% | 80,372 | Dec 18, 2024 | 13D/G |
| Yaii GP II, LLC | Other | 9.99% | 80,372 | Dec 18, 2024 | 13D/G |
| Mark Angelo | Other | 9.99% | 80,372 | Dec 18, 2024 | 13D/G |
| SC-Sigma Global Partners, LP | Other | 9.99% | 80,372 | Dec 18, 2024 | 13D/G |
| Sabby Volatility Warrant Master Fund, Ltd. | Corporation | 9.90% | 280,138 | Jan 20, 2026 | 13D/G |
| Sabby Management, LLC | Corporation | 9.90% | 280,138 | Jan 20, 2026 | 13D/G |
| Hal Mintz | Individual | 9.90% | 280,138 | Jan 20, 2026 | 13D/G |
| Squadron Master Fund LP | Partnership | 9.80% | 325,000 | May 27, 2026 | 13D/G |
| Squadron Capital Management LLC | IA, HC | 9.80% | 325,000 | May 27, 2026 | 13D/G |
| Matthew Sesterhenn | HC, IN | 9.80% | 325,000 | May 27, 2026 | 13D/G |
| William Blank | HC, IN | 9.80% | 325,000 | May 27, 2026 | 13D/G |
| Steven Boyd | HC, IN | 4.99% | 696,318 | Nov 14, 2024 | 13D/G |
| Armistice Capital, LLC | IA, OO | 4.99% | 696,318 | Nov 14, 2024 | 13D/G |
| Ikarian Capital, LLC | Investment adviser | 4.20% | 137,634 | Aug 14, 2026 | 13D/G |
| Neil Shahrestani | HC, IN | 4.20% | 137,634 | Aug 14, 2026 | 13D/G |
| Vivo Opportunity Cayman Fund, L.P. | Partnership | 2.20% | 72,535 | Jun 10, 2026 | 13D/G |
| Vivo Opportunity Cayman, LLC | Other | 2.20% | 72,535 | Jun 10, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,004,455 acquired · 394 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 23, 2026 | BUY | 4 | $1.32 | $5.28 | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 19, 2026 | BUY | 1,086 | $1.32 | $1.4K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 16, 2026 | BUY | 1 | $1.32 | $1.32 | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 15, 2026 | BUY | 984 | $1.32 | $1.3K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 14, 2026 | BUY | 8,021 | $1.33 | $10.7K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 13, 2026 | BUY | 564 | $1.33 | $750.12 | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 8, 2026 | BUY | 2,256 | $1.33 | $3.0K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 7, 2026 | BUY | 3,046 | $1.33 | $4.1K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 6, 2026 | BUY | 5,601 | $1.33 | $7.4K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 5, 2026 | BUY | 18,182 | $1.33 | $24.2K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 2, 2026 | BUY | 8,307 | $1.33 | $11.0K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Oct 1, 2026 | BUY | 16,431 | $1.33 | $21.8K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Sep 16, 2026 | BUY | 8,340 | $1.29 | $10.8K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Sep 15, 2026 | BUY | 54,256 | $1.30 | $70.4K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Sep 14, 2026 | BUY | 28,505 | $1.29 | $36.9K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | Jul 15, 2026 | BUY | 1,000 | $1.55 | $1.6K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 16, 2026 | BUY | 19 | $1.55 | $29.45 | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 15, 2026 | BUY | 13,761 | $1.55 | $21.3K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 14, 2026 | BUY | 4,882 | $1.55 | $7.6K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 16, 2026 | BUY | 2 | $1.55 | $3.10 | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 15, 2026 | BUY | 1,389 | $1.55 | $2.2K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 14, 2026 | BUY | 493 | $1.55 | $764.15 | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 2, 2026 | BUY | 1,460 | $1.55 | $2.3K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 1, 2026 | BUY | 3,946 | $1.55 | $6.1K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 30, 2026 | BUY | 545 | $1.54 | $839.30 | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 2, 2026 | BUY | 147 | $1.55 | $227.85 | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jul 1, 2026 | BUY | 398 | $1.55 | $616.90 | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 30, 2026 | BUY | 55 | $1.54 | $84.70 | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 8, 2026 | BUY | 29,518 | $1.52 | $44.9K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 5, 2026 | BUY | 49,966 | $1.57 | $78.4K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 4, 2026 | BUY | 6,125 | $1.57 | $9.6K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 3, 2026 | BUY | 7,069 | $1.55 | $11.0K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 2, 2026 | BUY | 20,753 | $1.52 | $31.5K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 1, 2026 | BUY | 14,838 | $1.55 | $23.0K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | May 29, 2026 | BUY | 16,164 | $1.57 | $25.4K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | May 21, 2026 | BUY | 30,882 | $1.69 | $52.2K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | May 20, 2026 | BUY | 51,056 | $1.56 | $79.6K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 8, 2026 | BUY | 2,982 | $1.52 | $4.5K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 5, 2026 | BUY | 5,045 | $1.57 | $7.9K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 4, 2026 | BUY | 618 | $1.57 | $970.26 | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 3, 2026 | BUY | 714 | $1.55 | $1.1K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 2, 2026 | BUY | 2,095 | $1.52 | $3.2K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | Jun 1, 2026 | BUY | 1,498 | $1.55 | $2.3K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | May 29, 2026 | BUY | 1,632 | $1.57 | $2.6K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | May 21, 2026 | BUY | 3,118 | $1.69 | $5.3K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | May 20, 2026 | BUY | 5,154 | $1.56 | $8.0K | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | May 19, 2026 | OTHER | 0 | — | — | Form 4 |
| Vivo Opportunity, LLC | 10 percent owner | May 19, 2026 | OTHER | 0 | — | — | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | May 19, 2026 | BUY | 200,000 | $1.50 | $299.8K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | May 19, 2026 | BUY | 200,000 | $1.56 | $312.1K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | May 19, 2026 | BUY | 68,551 | $1.60 | $109.7K | Form 4 |
| ADAR1 Capital Management, LLC | 10 percent owner | May 19, 2026 | OTHER | 0 | — | — | Form 4 |
| Johnson Shane Aaron | Sr VP & General Manager | Dec 19, 2025 | AWARD | 8,500 | $1.29 | $11.0K | Form 4 |
| Lemerond Nicole | director | Dec 19, 2025 | AWARD | 1,750 | $1.29 | $2.3K | Form 4 |
| Klompas Neil A | director | Dec 19, 2025 | AWARD | 1,750 | $1.29 | $2.3K | Form 4 |
| Jagpal Netta | Chief Financial Officer | Dec 19, 2025 | AWARD | 18,000 | $1.29 | $23.2K | Form 4 |
| WOUDENBERG MICHAEL | Chief Operating Officer | Dec 19, 2025 | AWARD | 18,000 | $1.29 | $23.2K | Form 4 |
| Bathery John Steven | director | Dec 19, 2025 | AWARD | 1,750 | $1.29 | $2.3K | Form 4 |
| HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | Dec 19, 2025 | AWARD | 13,000 | $1.29 | $16.8K | Form 4 |
| ADAMS ERIC A | director, officer: President & CEO | Dec 19, 2025 | AWARD | 35,000 | $1.29 | $45.1K | Form 4 |
| HULL ANDREW | director | Dec 19, 2025 | AWARD | 1,750 | $1.29 | $2.3K | Form 4 |
| HULL ANDREW | director | Dec 15, 2025 | DISPOSED | 14 | $1397.97 | $19.6K | Form 4 |
| ADAMS ERIC A | director, officer: President & CEO | Dec 15, 2025 | DISPOSED | 250 | $1397.97 | $349.5K | Form 4 |
| WOUDENBERG MICHAEL | Chief Operating Officer | Dec 15, 2025 | DISPOSED | 60 | $1397.97 | $83.9K | Form 4 |
| HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | Dec 15, 2025 | DISPOSED | 70 | $1397.97 | $97.9K | Form 4 |
| Bathery John Steven | director | Oct 14, 2025 | OTHER | 3,500 | $2.10 | $7.3K | Form 4 |
| Klompas Neil A | director | Oct 17, 2025 | AWARD | 3,500 | $2.10 | $7.3K | Form 4 |
| Klompas Neil A | director: | Oct 9, 2024 | OTHER | 0 | — | — | Form 4 |
| HULL ANDREW | director | Jan 11, 2025 | DISPOSED | 2 | $2860.21 | $5.7K | Form 4 |
| Johnson Shane Aaron | Sr VP & General Manager | Dec 20, 2024 | AWARD | 1,500 | $4.14 | $6.2K | Form 4 |
| Jagpal Netta | Chief Financial Officer | Dec 20, 2024 | AWARD | 3,750 | $4.14 | $15.5K | Form 4 |
| Lemerond Nicole | director | Dec 20, 2024 | AWARD | 550 | $4.14 | $2.3K | Form 4 |
| WOUDENBERG MICHAEL | Chief Operating Officer | Dec 20, 2024 | AWARD | 3,750 | $4.14 | $15.5K | Form 4 |
| Grove Janet P | director | Dec 20, 2024 | AWARD | 550 | $4.14 | $2.3K | Form 4 |
| HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | Dec 20, 2024 | AWARD | 2,750 | $4.14 | $11.4K | Form 4 |
| ADAMS ERIC A | director, officer: President & CEO | Dec 20, 2024 | AWARD | 6,250 | $4.14 | $25.9K | Form 4 |
| Baldasare Bryan T | director | Dec 20, 2024 | AWARD | 550 | $4.14 | $2.3K | Form 4 |
| HULL ANDREW | director | Dec 20, 2024 | AWARD | 550 | $4.14 | $2.3K | Form 4 |
| MANCINI ALEXANDRA DIANE JANET | other: Consultant | Jul 31, 2024 | SELL | 240 | $0.18 | $42.31 | Form 4 |
| WOUDENBERG MICHAEL | Chief Operating Officer | May 27, 2024 | DISPOSED | 394 | $263.18 | $103.7K | Form 4 |
| HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | May 27, 2024 | DISPOSED | 545 | $263.18 | $143.4K | Form 4 |
| ADAMS ERIC A | director, officer: President & CEO | May 27, 2024 | DISPOSED | 1,139 | $263.18 | $299.8K | Form 4 |
| MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | May 27, 2024 | DISPOSED | 485 | $263.18 | $127.6K | Form 4 |
| HULL ANDREW | director | Jan 14, 2024 | DISPOSED | 42 | $307.01 | $12.9K | Form 4 |
| HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | Mar 4, 2024 | DISPOSED | 309 | $364.72 | $112.7K | Form 4 |
| MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | Jan 21, 2024 | DISPOSED | 121 | $312.73 | $37.8K | Form 4 |
| Jagpal Netta | Chief Financial Officer | Feb 20, 2024 | DISPOSED | 50,000 | $0.37 | $18.5K | Form 4 |
| HULL ANDREW | director | Feb 21, 2024 | BUY | 37,500 | $0.39 | $14.6K | Form 4 |
| ADAMS ERIC A | director, officer: President & CEO | Feb 20, 2024 | BUY | 41,600 | $0.36 | $14.9K | Form 4 |
| Johnson Shane Aaron | Sr VP & General Manager | Dec 23, 2023 | AWARD | 40,000 | $0.37 | $14.8K | Form 4 |
| Lemerond Nicole | director | Dec 23, 2023 | AWARD | 7,100 | $0.37 | $2.6K | Form 4 |
| WOUDENBERG MICHAEL | Chief Operating Officer | Dec 23, 2023 | AWARD | 65,000 | $0.37 | $24.1K | Form 4 |
| Tegge Jonathan | Interim CFO | Dec 23, 2023 | AWARD | 30,000 | $0.37 | $11.1K | Form 4 |
| Grove Janet P | director | Dec 23, 2023 | AWARD | 7,100 | $0.37 | $2.6K | Form 4 |
| HSU ERIC C | Sr. VP, Pre-Clinical Res/Dev | Dec 23, 2023 | AWARD | 45,000 | $0.37 | $16.6K | Form 4 |
| ADAMS ERIC A | director, officer: President & CEO | Dec 23, 2023 | AWARD | 136,000 | $0.37 | $50.3K | Form 4 |
| Baldasare Bryan T | director | Dec 23, 2023 | AWARD | 7,100 | $0.37 | $2.6K | Form 4 |
| MANCINI ALEXANDRA DIANE JANET | Sr VP, Clinical Reg Affairs | Dec 23, 2023 | AWARD | 45,000 | $0.37 | $16.6K | Form 4 |
| HULL ANDREW | director | Dec 23, 2023 | AWARD | 7,100 | $0.37 | $2.6K | Form 4 |
| WOUDENBERG MICHAEL | Chief Operating Officer | Dec 5, 2023 | DISPOSED | 848 | $270.36 | $229.3K | Form 4 |